Biogen
BIIB
A$198.90
Share price
-0.31%
Change (1 day)
-41.98%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Biogen (BIIB) - Net assets
Net assets on the balance sheet as of March 2025 : A$25.92 Billion
According to Biogen's latest financial reports the company has A$25.92 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Biogen - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $A$26.87 B | 23.72% |
| 2023-12-31 | $A$21.72 B | 10.41% |
| 2022-12-31 | $A$19.67 B | 30.14% |
| 2021-12-31 | $A$15.11 B | 8.78% |
| 2020-12-31 | $A$13.89 B | -27.06% |
| 2019-12-31 | $A$19.05 B | 2.99% |
| 2018-12-31 | $A$18.49 B | 14.63% |
| 2017-12-31 | $A$16.13 B | -4.1% |
| 2016-12-31 | $A$16.82 B | 30.75% |
| 2015-12-31 | $A$12.86 B | -2.61% |
| 2014-12-31 | $A$13.21 B | 36.72% |
| 2013-12-31 | $A$9.66 B | 44.23% |
| 2012-12-31 | $A$6.70 B | 6.91% |
| 2011-12-31 | $A$6.26 B | 16.84% |
| 2010-12-31 | $A$5.36 B | -23.04% |
| 2009-12-31 | $A$6.97 B | -15.7% |
| 2008-12-31 | $A$8.26 B | 30.63% |
| 2007-12-31 | $A$6.33 B | -30.21% |
| 2006-12-31 | $A$9.06 B | -3.9% |
| 2005-12-31 | $A$9.43 B | 6.99% |
| 2004-12-31 | $A$8.82 B | -7.04% |
| 2003-12-31 | $A$9.48 B | 381.78% |
| 2002-12-31 | $A$1.96 B | -25.48% |
| 2001-12-31 | $A$2.64 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | A$9.47 B | -63.44% | 🇺🇸 USA |
 Gilead Sciences GILD | A$29.13 B | 12.36% | 🇺🇸 USA |
 AbbVie ABBV | A$2.23 B | -91.39% | 🇺🇸 USA |
 Pfizer PFE | A$138.40 B | 433.83% | 🇺🇸 USA |
 Johnson & Johnson JNJ | A$119.27 B | 360.04% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -A$0.29 Billion | -101.09% | 🇺🇸 USA |
 Sanofi SNY | A$123.00 B | 374.41% | 🇫🇷 France |
 Bio-Rad Laboratories BIO | A$10.19 B | -60.66% | 🇺🇸 USA |
 Illumina ILMN | A$3.61 B | -86.05% | 🇺🇸 USA |
 Qiagen QGEN | A$5.20 B | -79.93% | 🇳🇱 Netherlands |